1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc.

OCUP
Ocuphire Pharma, Inc.US flagNASDAQ Capital Market
1.17
USD
-0.16
- -
31.74MMarket Cap

Income Statement (USD)

MCPAPIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
1
40
19
+ Sales & Services Revenue
- -
- -
1
40
19
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-1
-40
-19
- Operating Expenses
4
9
23
22
30
+ Selling, General & Admin
2
3
8
7
12
+ Research & Development
2
7
15
14
18
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-4
-9
-23
18
-11
- Non-Operating (Income) Loss
2
15
34
- -
-1
+ Interest Expense, Net
1
7
- -
- -
- -
+ Interest Expense
1
7
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
1
8
34
- -
-1
Pretax Income
-6
-25
-57
18
-10
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-6
-25
-57
18
-10
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-6
-25
-57
18
-10
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-6
-25
-57
18
-10
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-6
-25
-57
18
-10
EBIT
-4
-9
-23
18
-11
EBITDA
-4
-9
-23
18
-11
EBITDA Margin (%)
- -
- -
-3,854.16
45.75
-55.42
EBITA
-4
-9
-23
18
-11
Gross Margin (%)
- -
- -
100
100
100
Operating Margin (%)
- -
- -
-3,854.84
45.74
-55.45
Profit Margin (%)
- -
- -
-9,625.3
44.89
-52.42
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
7
5
15
20
22
Basic EPS, GAAP
-0.87
-5.28
-3.82
0.9
-0.46
Basic EPS from Cont Ops
-0.87
-5.28
-3.82
0.9
-0.46
Diluted Weighted Avg Shares
7
5
15
21
22
Diluted EPS, GAAP
-0.87
-5.28
-3.82
0.87
-0.46
Diluted EPS from Cont Ops
-0.87
-5.28
-3.82
0.87
-0.46

Balance Sheet (USD)

MCPAPIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
2
18
26
49
54
+ Cash, Cash Equivalents & STI
2
16
25
43
51
+ Cash & Cash Equivalents
2
16
25
43
51
+ ST Investments
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
5
2
+ Accounts Receivable, Net
- -
- -
- -
1
1
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
4
1
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
Total Assets
2
18
26
49
54
+ Payables & Accruals
1
3
3
3
4
+ Accounts Payable
- -
1
2
1
2
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
2
1
2
+ ST Debt
6
- -
1
- -
- -
+ ST Borrowings
6
- -
1
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
+ Other ST Liabilities
3
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
3
- -
- -
- -
- -
Total Current Liabilities
9
3
4
3
4
+ LT Debt
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
28
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
28
- -
- -
- -
Total Noncurrent Liabilities
- -
28
- -
- -
- -
Total Liabilities
9
31
4
3
4
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
19
112
118
131
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
19
112
118
131
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-8
-33
-89
-71
-81
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-8
-13
22
46
50
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-8
-13
22
46
50
Total Liabilities & Equity
2
18
26
49
54
Shares Outstanding
7
11
19
21
24
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
Net Debt
4
-16
-24
-43
-51
Net Debt to Equity
-54.63
121.77
-107.98
-92.2
-101.19
Tangible Common Equity Ratio
-423.77
-76.16
85.22
94.38
92.51
Current Ratio
0.19
5.55
6.76
17.79
13.35
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

MCPAPIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-6
-25
-57
18
-10
+ Depreciation & Amortization
- -
- -
- -
- -
- -
+ Non-Cash Items
2
17
37
2
5
+ Stock-Based Compensation
- -
2
2
2
4
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
15
35
- -
1
+ Chg in Non-Cash Work Cap
- -
1
- -
-6
4
+ (Inc) Dec in Accts Receiv
- -
- -
- -
-5
3
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
- -
- -
+ Inc (Dec) in Accts Payable
- -
2
- -
-1
1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-4
-7
-19
14
-1
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
21
28
4
9
+ Increase in Capital Stock
- -
21
28
4
9
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
1
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
1
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
5
2
1
-1
- -
+ Cash From Debt
5
2
1
- -
- -
+ Repayments of Debt
- -
- -
- -
-1
- -
+ Other Financing Activities
- -
-2
-1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
5
21
28
4
9
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
1
15
8
18
8
EBITDA
-4
-9
-23
18
-11
EBITDA Margin (%)
- -
- -
-3,854.16
45.75
-55.42
Free Cash Flow
-4
-7
-19
14
-1
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
14
- -
Free Cash Flow to Equity
- -
-5
-19
14
-1
Free Cash Flow per Basic Share
-0.51
-1.46
-1.3
0.72
-0.05
Price/Free Cash Flow
-15.19
-4.45
-2.86
5.08
-58.44
Cash Flow to Net Income
0.58
0.28
0.34
0.8
0.11
Capital Expenditures
- -
- -
- -
- -
- -